Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction Notice: TWIST1's Role in Activating Cancer Stem Cell Markers and Facilitating Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma

  • By

  • Sima Ardalan Khales

  • Sina Mozaffari‑Jovin

  • Dirk Geerts

  • Mohammad Reza Abbaszadegan

  • September 11, 2026

Share

  • 1

    The article titled 'TWIST1's Role in Activating Cancer Stem Cell Markers and Facilitating Epithelial-Mesenchymal Transition' was retracted.

  • 2

    Concerns arose regarding data integrity, specifically similarities identified between certain cell images presented.

  • 3

    The Editors lost confidence in the article's data and conclusions due to unresolved issues related to the images.

  • 4

    No response was received from the authors regarding the retraction notice sent by the Publisher.

  • 5

    The article was published in BMC Cancer, volume 22, article 1272 in 2022.

Original Source(s)

Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma

  • by Sima Ardalan Khales, Sina Mozaffari‑Jovin, Dirk Geerts, Mohammad Reza Abbaszadegan

  • September 11, 2026

Related Content

Correction: Case Report: Complete response and prolonged survival to alectinib in a NSCLC patient with metastases harboring a rare WDR43::ALK structural deletion

Case Report: Donor-derived early T-cell precursor acute lymphoblastic leukemia following an allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia

Case Report: Treatment of an unresectable mucoepidermoid carcinoma with osimertinib